# OPANA ER
> **NDA021610** · New Drug Application · Sponsor: ENDO OPERATIONS · Approved 2006-06-22
## Drug
- **FDA Application Number:** NDA021610
- **Application type:** New Drug Application
- **Brand name:** OPANA ER
- **Generic name:** Oxymorphone Hydrochloride
- **Active ingredients:** OXYMORPHONE HYDROCHLORIDE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** ENDO OPERATIONS
- **First approval:** 2006-06-22
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021610)
---
*AI Analytics · CC0 1.0*